Title: Targeting the myofibroblast genetic switch: inhibitors of myocardin-related transcription factor/serum response factor-regulated gene transcription prevent fibrosis in a murine model of skin injury.
Journal: The Journal of pharmacology and experimental therapeutics 20140601
Title: Redox modification of nuclear actin by MICAL-2 regulates SRF signaling.
Journal: Cell 20140130
Title: Optimization of novel nipecotic bis(amide) inhibitors of the Rho/MKL1/SRF transcriptional pathway as potential anti-metastasis agents.
Journal: Bioorganic & medicinal chemistry letters 20130701
Title: Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance.
Journal: The Journal of clinical investigation 20110301
Title: Combination of small molecules enhances differentiation of mouse embryonic stem cells into intermediate mesoderm through BMP7-positive cells.
Journal: Biochemical and biophysical research communications 20100319
Title: Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423.
Journal: Bioorganic & medicinal chemistry letters 20100115
Title: Signaling through Rho GTPase pathway as viable drug target.
Journal: Current medicinal chemistry 20090101
Title: CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Journal: Molecular cancer therapeutics 20070801
Title: Evelyn CR, et al. Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423. Bioorg Med Chem Lett. 2010 Jan 15;20(2):665-72.
Title: Jin W, et al. Increased SRF transcriptional activity in human and mouse skeletal muscle is a signature of insulin resistance. J Clin Invest. 2011 Mar;121(3):918-29.
Title: Chong NW, et al. STARS is essential to maintain cardiac development and function in vivo via a SRF pathway. PLoS One. 2012;7(7):e40966.
Title: Duggirala A, et al. cAMP-induced actin cytoskeleton remodelling inhibits MKL1-dependent expression of the chemotactic and pro-proliferative factor, CCN1. J Mol Cell Cardiol. 2014 Nov 18;79C:157-168.
